People: Prana Biotechnology Ltd (PRAN.O)
24 Oct 2014
Mr. Lawrence Gozlan has served as Non-Executive Independent Director of Prana Biotechnology Ltd since August 8, 2011. Mr. Gozlan, a biotechnology investor and advisor, is the Chief Investment Officer and Founder of Scientia Capital, a specialized global investment fund focused exclusively in life sciences. Scientia Capital was founded to provide high level experience and to manage investments for high net worth individuals, family offices and institutional investors seeking exposure to the biotechnology industry. Mr. Gozlan commenced his position with Scientia Capital in June 2006. Previously, Mr. Gozlan was responsible for the biotechnology investment portfolio in Australia as the institutional biotechnology analyst at the Queensland Investment Corporation (QIC), an investment fund with over AU$60 billion worth of assets under management. Mr. Gozlan also worked as the senior biotechnology analyst in the equities team at Foster Stock broking, and gained senior corporate finance experience advising life sciences companies at Deloitte. Mr. Gozlan is an investment advisor to several companies in the biotechnology industry, presented at numerous international healthcare conferences, and has been featured in various published media as an experienced person on investing in life sciences. He holds a Bachelor of Science with Honors in Microbiology and Immunology from the University of Melbourne, specializing in neurodegenerative diseases. He is Chairman of the Nomination Committee.
|Total Annual Compensation, AUD||Long-Term Incentive Plans, AUD||All Other, AUD||Fiscal Year Total, AUD|